본문으로 건너뛰기
← 뒤로

Holistic determination of ends of cfDNA molecules.

Cell genomics 2026 Vol.6(3) p. 101142

Jiang P, Ma ML, Qiao R, Shi Y, Liu J, Zhou Q, Peng W, Lam WKJ, Bai J, Choy LYL, Tsui WHA, Malki Y, Kang G, Yu SCY, Xiong D, Wong GLH, Chan LL, Wong J, Chan SL, Wong VWS, Chan KCA, Lo YMD

📝 환자 설명용 한 줄

Cell-free DNA (cfDNA) end motifs serve as fragmentomics biomarkers for cancer.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Jiang P, Ma ML, et al. (2026). Holistic determination of ends of cfDNA molecules.. Cell genomics, 6(3), 101142. https://doi.org/10.1016/j.xgen.2026.101142
MLA Jiang P, et al.. "Holistic determination of ends of cfDNA molecules.." Cell genomics, vol. 6, no. 3, 2026, pp. 101142.
PMID 41653917

Abstract

Cell-free DNA (cfDNA) end motifs serve as fragmentomics biomarkers for cancer. Prior studies primarily focused on 5' ends, whereas 3' ends were overlooked due to artifactual modification in existing sequencing protocols. We utilized single-stranded library preparation ("2-end sequencing") to assess the native 5' and 3' end motifs (EM5 and EM3, respectively). Additionally, we demonstrated diagnostic power from the nucleotide motifs located immediately upstream and downstream of 5' and 3' ends, named pre-end motifs (PREMs) and post-end motifs (POEMs). These fragmentomics markers collectively achieved an area under the curve (AUC) of 0.95 for hepatocellular carcinoma (HCC) detection. Fragmentomics-based methylation analysis of 3' ends (3' FRAGMA) improved detection of HCC (AUC: 0.97). We further developed "4-end sequencing" to interrogate both ends of both strands of a double-stranded cfDNA molecule, enhancing fragmentomics-based cancer detection. Holistic end profiling adds to the armamentarium of liquid biopsy and sheds light on the biology of cfDNA fragmentation.

MeSH Terms

Humans; Liver Neoplasms; Cell-Free Nucleic Acids; Carcinoma, Hepatocellular; Biomarkers, Tumor; DNA Methylation; Nucleotide Motifs; Sequence Analysis, DNA; Liquid Biopsy; High-Throughput Nucleotide Sequencing

같은 제1저자의 인용 많은 논문 (5)